Dinuclear platinum anticancer complexes with fluorescent N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones: Cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles

Journal of Biological Inorganic Chemistry

Volumn 10, Issue 3, 2005, Pages 305-315

  Kalayda, Ganna V ^a   Jansen, Bart A J ^a   Wielaard, Peter ^a   Tanke, Hans J ^b   Reedijk, Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cisplatin resistance; Endocytosis; Fluorescence microscopy; Lysosomes

Indexed keywords

ANTHRACENE DERIVATIVE; CISPLATIN DERIVATIVE; N,N' BIS(2 AMINOETHYL) 1,4 DIAMINOANTHRACENE 9,10 DIONE; N,N' BIS(3 AMINOPROP 1 YL) 1,4 DIAMINOANTHRACENE 9,10 DIONE; N,N' BIS(4 AMINOBUT 1 YL) 1,4 DIAMINOANTHRACENE 9,10 DIONE; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; EVALUATION; FLUORESCENCE MICROSCOPY; GOLGI COMPLEX; HUMAN; HUMAN CELL; LYSOSOME; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; LIGANDS; MOLECULAR STRUCTURE; PLATINUM;

EID: 20044388763     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-005-0643-7     Document Type: Article

References (50)

1. Ozols RF, Williams SD (1989) Curr Probl Cancer 13:287-335
2. Ozols RF (1992) Curr Probl Cancer 16:63-126
3. Wong E, Giandomenico CM (1999) Chem Rev 99:2451-2466
4. Reedijk J (2003) Proc Natl Acad Sci USA 100:3611-3616
5. Muggia FM, Los G (1993) Stem Cells 11:182-193
6. Jassem J (1999) Ann Oncol 10:77-82
7. Perez RP (1998) Eur J Cancer 34:1535-1542
8. Andrews P, Howell S (1990) Cancer Cells 2:35-43
9. Perez R, Gamilton T, Ozols R (1990) Pharmacol Ther 48:19-27
10. Gately DP, Howell SB (1993) Br J Cancer 67:1171-1176
11. Kelland LR (2000) Drugs 59:1-8
12. Fuertes MA, Castilla J, Alonso C, Perez JM (2003) Curr Med Chem 10:257-266
13. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Science 241:1813-1815
14. Schilder RJ, Hall L, Monks A (1990) Int J Cancer 45:416-422
15. Parker RJ, Eastman A, Bostick-Burton F, Reed E (1991) J Clin Invest 87:722-777
16. Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC (1994) Biochem Pharmacol 47:689-697
17. Dempke W, Voigt W, Grothey A, Hill BT, Schmoll HJ (2000) Anti-Cancer Drugs 11:225-236
18. Niedner H, Christen R, Lin X, Kondo A, Howell SB (2001) Mol Pharmacol 60:1153-1160
19. Fritsche M, Haessler C, Brandner G (1993) Oncogene 8:307-318
20. Jansen BAJ, Wielaard P, Kalayda GV, Ferrari M, Molenaar C, Tanke HJ, Brouwer J, Reedijk J (2004) J Biol Inorg Chem 9:403-413
21. Kalayda GV, Jansen BAJ, Molenaar C, Wielaard P, Tanke HJ, Reedijk J (2004) J Biol Inorg Chem 9:414-422
22. Perego P, Righetti SC, Supino R, Delia D, Caserini C, Carenini N, Bedogne B, Broome E, Krajewski S, Reed JC, Zunino F (1997) Apoptosis 2:540-548
23. Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F (1999) Mol Pharmacol 55:1108-1108
24. Perez JM, Montero EI, Quiroga AG, Fuertes MA, Alonso C, Navarro-Ranninger C (2001) Metal-Based Drugs 8:29-37
25. Perez JM, Kelland LR, Montero EI, Boxall FE, Fuertes MA, Alonso C, Navarro-Ranninger C (2003) Mol Pharmacol 63:933-944
26. Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F (2000) Clin Cancer Res 6:2626-2634
27. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Cancer Res 48:589-601
28. Hindenburg AA, Gervasoni JE Jr, Krishna S, Stewart VJ, Rosado M, Lutzky J, Bhalla K, Baker MA, Taub RN (1989) Cancer Res 49:4607-4614
29. Arancia G, Calcabrini A, Meschini S, Molinari A (1998) Cytotechnology 27:95-111
30. Bour-Dill C, Gramain MP, Merlin JL, Marchal S, Guillemin F (2000) Cytometry 39:16-25
31. Beyer U, Rothen-Rutishauser B, Unger C, Wunderli-Allenspach H, Kratz F (2001) Pharm Res 18:29-38
32. Traub LM, Kornfeld S (1997) Curr Opin Cell Biol 9:527-533
33. Molenaar C, Teuben JM, Heetebrij RJ, Tanke HJ, Reedijk J (2000) J Biol Inorg Chem 5:655-665
34. Liang XJ, Shen DW, Garfield S, Gottesman MM (2003) Cancer Res 63:5909-5916
35. Chauhan SS, Liang XJ, Su AW, Pai-Panandiker A, Shen DW, Hanover JA, Gottesman MM (2003) Br J Cancer 88:1327-1334
36. Altan N, Chen Y, Schindler M, Simon SM (1998) J Exp Med 187:1583-1598
37. Gong YP, Duvvuri M, Krise JP (2003) J Biol Chem 278:50234-50239
38. Larsen AK, Escargueil AE, Skladanowski A (2000) Pharm Ther 85:217-229
39. Cullinane C, Wickham G, McFadyen WD, Denny WA, Palmer BD, Phillips DR (1993) Nucleic Acids Res 21:393-400
40. Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA, McFadyen WD (1992) J Biol Chem 267:18805-18809
41. Temple MD, McFadyen WD, Holmes RJ, Denny WA, Murray V (2000) Biochemistry 39:5593-5599
42. Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467-2498
43. Center MS (1993) Cytotechnology 12:109-125
44. Warren L, Malarska A, Jardillier JC (1995) Cancer Chemother Pharmacol 35:267-269
45. Rajagopal A, Simon SM (2003) Mol Biol Cell 14:3389-3399
46. Boscoboinik D, Gupta RS, Epand RM (1990) Br J Cancer 61:568-572
47. Ouar Z, Lacave R, Bens M, Vandewalle A (1999) Cell Biol Toxicol 15:91-100
48. Mellman I, Fuchs R, Helenius A (1986) Ann Rev Biochem 55:663-700
49. van Deurs B, Petersen OW, Olsnes S, Sandvig K (1989) Int Rev Cytol 117:131-177
50. Cosson P, de Curtis I, Pouyssegur J, Griffiths G, Davoust J (1989) J Cell Biol 108:377-387